1-5 of 5
Steve Ziesmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IL-21 and IL-6 Mediate Interactions Between T Cells and Malignant B Cells in the Bone Marrow Microenvironment in Waldenstrom's Macroglobulinemia

Lucy S. Hodge, PharmD, Ph.D., Steve Ziesmer, Frank J Secreto, Ph.D., Zhi-Zhang Yang, MD, Anne Novak, Morie Abraham A Gertz, MD, Stephen M Ansell, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 1554.
https://doi.org/10.1182/blood.V120.21.1554.1554
Published: 2012
Journal Articles

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation

Mamta Gupta, Jing Jing Han, Mary Stenson, Matthew Maurer, Linda Wellik, Guangzhen Hu, Steve Ziesmer, Ahmet Dogan, Thomas E. Witzig
Journal: Blood
Blood (2012) 119 (12): 2844–2853.
https://doi.org/10.1182/blood-2011-10-388538
Published: 2012
Includes: Supplemental data
Journal Articles

Dysregulation of GPR34 in Indolent Lymphomas and Its Function As a Novel Regulator of Cell Growth and Gene Expression

Anne J. Novak, Ph.D., Takashi Akasaka, MD, PhD, Michelle K Manske, Esteban Braggio, PhD, Tammy Price-Troska, Steve Ziesmer, Secreto Frank, Ph.D., Rafael Fonseca, MD, Mamta Gupta, PhD, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, Ellen McPhail, MD, James R Cerhan, MD, PhD, Stephen Ansell
Journal: Blood
Blood (2011) 118 (21): 1570.
https://doi.org/10.1182/blood.V118.21.1570.1570
Published: 2011
Journal Articles

IL-21 in the Bone Marrow Microenvironment Contributes to IgM Secretion and Proliferation of Malignant Cells in Waldenstrom's Macroglobulinemia

Lucy S. Hodge, PharmD, PhD, Steve Ziesmer, Thomas E. Witzig, MD, Anne J. Novak, Ph.D., Stephen M. Ansell, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 770.
https://doi.org/10.1182/blood.V118.21.770.770
Published: 2011
Journal Articles

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM-MGUS) Identifies Potential Targets for Drug Therapy.

Irene M. Ghobrial, MD, Alexey A. Leontocich, PhD, Jeanette E. Eckel, PhD, Michael Timm, BS, Steve Ziesmer, BS, Antje Hoering, PhD, Miguel Cabanela, MD, Alex Nehme, MD, Philip R. Greipp, MD, Rafael Fonseca, MD, Morie A. Gertz, MD, Thomas E. Witzig, MD
Journal: Blood
Blood (2004) 104 (11): 787.
https://doi.org/10.1182/blood.V104.11.787.787
Published: 2004